ACT I among primes for chemical and biological defense tasks
- By Defense Systems Staff
- Jan 24, 2013
Advanced Concept Technologies International (ACT I) is one of the small business prime contractors selected to furnish acquisition support services to the joint program office managing the U.S. military's chemical and biological defense program, the company said Jan. 17.
The potential value to all awardees of the Joint Program Executive Office for Chemical and Biological Defense's (JPEO-CBD) Omnibus Program, Engineering and Technical Support indefinite-delivery, indefinite-quantity contract is $495 million over five years. Seventy contractors were selected in six domains for the multiple-award contract, according to a government award notice.
JPEO-CBD is responsible for research, development, acquisition, fielding, and life-cycle support of chemical and biological defense equipment and medical countermeasures. To carry out its mission, the organization has eight joint project managers who direct and manage the acquisition and fielding of CBD and reconnaissance systems, individual and collective protection systems and decontamination systems. The project managers also coordinate information management systems, medical devices, drugs and vaccines, and installation and force protection systems.
ACT I of Alexandria, Va., is a privately owned knowledge services provider with expertise in acquisition and life-cycle management approaches for the defense, space and energy sectors.